New research delves into the DNA details and chromatin structures that may predict prognosis in early-stage lung ...

This paper explores the potential of mitochondrial-associated programmed-cell-death (mtPCD) patterns as biomarkers for ...

There is an urgent need for precision immunotherapy strategies that simultaneously target both tumor cells and immune cells ...

Professor Zeng Zexian's team from the Center for Quantitative Biology at the Peking University Academy for Advanced Interdisciplinary Studies, in collaboration with the Peking University-Tsinghua ...

Shares of Portage Biotech Inc. more than doubled in after-hours trading on Thursday as the company reported promising ...

Ischemic heart disease is a common consequence of coronary artery disease (CAD), which is primarily driven by atherosclerosis, a chronic inflammatory ...

Recent findings suggest that mitochondrial-targeted therapy, either by reducing reactive oxygen species production or ...

Professor Zeng Zexian's team from the Center for Quantitative Biology at the Peking University Academy for Advanced ...

Early results show that the combination of VXM01 plus avelumab demonstrated tolerable safety in recurrent glioblastoma.

Results from Phase 2a Trial demonstrate a good safety and tolerability profile of VXM01 and Avelumab Combination Therapy in Glioblastoma, supporting further investigation of VXM01 BASEL, Switzerland, ...

Professor Zeng Zexian’s team from the Center for Quantitative Biology at the Peking University Academy for Advanced Interdisciplinary Studies, in collaboration with the Peking University-Tsinghua ...